Quick Answer
Gain Therapeutics, Inc. reported Shares Outstanding of 42.07 million shares for fiscal year 2025.
Gain Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 42.07M | +55.1% |
| 2024 | 27.13M | +67.4% |
| 2023 | 16.21M | +36.4% |
| 2022 | 11.88M | +0.0% |
| 2021 | 11.88M | +195.4% |
| 2021 | 4.02M | +13.5% |
| 2020 | 3.54M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 35.98M | +38.6% | +16.9% |
| June 30, 2025 | 30.77M | +22.2% | +7.0% |
| March 31, 2025 | 28.75M | +59.3% | +5.9% |
| December 31, 2024 | 27.13M | +67.4% | +4.5% |
| September 30, 2024 | 25.96M | +103.1% | +3.1% |
| June 30, 2024 | 25.17M | +99.3% | +39.5% |
| March 31, 2024 | 18.04M | +49.3% | +11.3% |
| December 31, 2023 | 16.21M | +36.4% | +26.8% |
- Gain Therapeutics, Inc. showed an increase of +55.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Gain Therapeutics, Inc.’s shares outstanding has grown by 1087.5% (from 3.54 million shares to 42.07 million shares).
- The most recent figure is from Gain Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: